全文获取类型
收费全文 | 8837篇 |
免费 | 953篇 |
国内免费 | 598篇 |
专业分类
耳鼻咽喉 | 205篇 |
儿科学 | 121篇 |
妇产科学 | 55篇 |
基础医学 | 493篇 |
口腔科学 | 86篇 |
临床医学 | 930篇 |
内科学 | 824篇 |
皮肤病学 | 99篇 |
神经病学 | 318篇 |
特种医学 | 301篇 |
外科学 | 346篇 |
综合类 | 1405篇 |
现状与发展 | 1篇 |
预防医学 | 766篇 |
眼科学 | 40篇 |
药学 | 2016篇 |
4篇 | |
中国医学 | 2239篇 |
肿瘤学 | 139篇 |
出版年
2024年 | 25篇 |
2023年 | 230篇 |
2022年 | 263篇 |
2021年 | 431篇 |
2020年 | 383篇 |
2019年 | 319篇 |
2018年 | 339篇 |
2017年 | 358篇 |
2016年 | 384篇 |
2015年 | 344篇 |
2014年 | 561篇 |
2013年 | 775篇 |
2012年 | 531篇 |
2011年 | 508篇 |
2010年 | 414篇 |
2009年 | 413篇 |
2008年 | 418篇 |
2007年 | 406篇 |
2006年 | 461篇 |
2005年 | 430篇 |
2004年 | 372篇 |
2003年 | 323篇 |
2002年 | 211篇 |
2001年 | 231篇 |
2000年 | 188篇 |
1999年 | 118篇 |
1998年 | 112篇 |
1997年 | 99篇 |
1996年 | 68篇 |
1995年 | 94篇 |
1994年 | 83篇 |
1993年 | 63篇 |
1992年 | 68篇 |
1991年 | 43篇 |
1990年 | 56篇 |
1989年 | 54篇 |
1988年 | 40篇 |
1987年 | 44篇 |
1986年 | 19篇 |
1985年 | 32篇 |
1984年 | 18篇 |
1983年 | 11篇 |
1982年 | 13篇 |
1981年 | 3篇 |
1980年 | 4篇 |
1979年 | 8篇 |
1978年 | 6篇 |
1977年 | 4篇 |
1976年 | 6篇 |
1973年 | 3篇 |
排序方式: 共有10000条查询结果,搜索用时 78 毫秒
1.
《Cancer cell》2022,40(10):1223-1239.e6
2.
3.
4.
《Diabetes & Metabolic Syndrome: Clinical Research & Reviews》2019,13(1):408-412
AimsChild growth is one of the important health indicators in pediatric care. Few studies focused on the impact of prenatal exposure to gestational diabetes mellitus (GDM) on growth trajectories particular in early years of childhood. The aim of this study was identifying growth pattern of GDM exposed offspring's, comparison with new WHO child growth standards.Methods and materialsIn a population-based Longitudinal study 438 infants exposed to gestational diabetes in utero, aged 0–24 months, born between 2014 and 2016 with at least 9 visits in first 2 years of life were enrolled. Twenty health centers of Ahvaz city (Capital of Khuzestan province, located in south western of Iran) and two referral centers for neonatal hypothyroidism involved the study.ResultsOf 438 GDM exposed infants, 54.6% were boys. Incidence of low birth weight and macrosomia were 4.6% and 8.7% respectively.Results4.6% had birth weight less than 2500gr and 8.7% was rate of macrosomia. Boys had higher weight and BMI than girls. Peak of BMI was 17.8 (±2.07) at 6 months after Gender was significant factor in predicted of BMI growth trajectories in GDM exposed children (p = 0.001). BMI in GDM exposed infants, in first 2 years of life was higher than WHO growth standards 2006 (P < 0.01).ConclusionMedians of BMI in GDM exposed infants in all measures was higher than WHO reference data 2006 (P < 0.01). Obesity prevention programs must be priority in GDM exposed infants. 相似文献
5.
6.
7.
《Vaccine》2019,37(50):7408-7418
The development of vaccines against herpes simplex virus (HSV) is an important global goal for sexual and reproductive health. A key priority to advance development of HSV vaccines is the definition of preferred product characteristics (PPCs), which provide strategic guidance on World Health Organization (WHO) preferences for new vaccines, specifically from a low- and middle-income country (LMIC) perspective. To start the PPC process for HSV vaccines, the WHO convened a global stakeholder consultation in March 2017, to define the priority public health needs that should be addressed by HSV vaccines and discuss the key considerations for HSV vaccine PPCs, particularly for LMICs. Meeting participants outlined an initial set of overarching public health goals for HSV vaccines in LMICs, which are: to reduce the acquisition of HIV associated with HSV-2 infection in high HIV-prevalence populations and to reduce the burden of HSV-associated disease, including mortality and morbidity due to neonatal herpes and impacts on sexual and reproductive health. Participants also considered the role of prophylactic versus therapeutic vaccines, whether both HSV-2 and HSV-1 should be targeted, important target populations, and infection and disease endpoints for clinical trials. This article summarizes the main discussions from the consultation. 相似文献
8.
Milan Milojevic Patrick W. Serruys Joseph F. Sabik David E. Kandzari Erick Schampaert Ad J. van Boven Ferenc Horkay Imre Ungi Samer Mansour Adrian P. Banning David P. Taggart Manel Sabaté Anthony H. Gershlick Andrzej Bochenek Jose Pomar Nicholas J. Lembo Nicolas Noiseux John D. Puskas Arie Pieter Kappetein 《Journal of the American College of Cardiology》2019,73(13):1616-1628
Background
The randomized EXCEL (Evaluation of XIENCE versus Coronary Artery Bypass Surgery for Effectiveness of Left Main Revascularization) trial reported a similar rate of the 3-year composite primary endpoint of death, myocardial infarction (MI), or stroke in patients with left main coronary artery disease (LMCAD) and site-assessed low or intermediate SYNTAX scores treated with percutaneous coronary intervention (PCI) and coronary artery bypass grafting (CABG). Whether these results are consistent in high-risk patients with diabetes, who have fared relatively better with CABG in most prior trials, is unknown.Objectives
In this pre-specified subgroup analysis from the EXCEL trial, the authors sought to examine the effect of diabetes in patients with LMCAD treated with PCI versus CABG.Methods
Patients (N = 1,905) with LMCAD and site-assessed low or intermediate CAD complexity (SYNTAX scores ≤32) were randomized 1:1 to PCI with everolimus-eluting stents versus CABG, stratified by the presence of diabetes. The primary endpoint was the rate of a composite of all-cause death, stroke, or MI at 3 years. Outcomes were examined in patients with (n = 554) and without (n = 1,350) diabetes.Results
The 3-year composite primary endpoint was significantly higher in diabetic compared with nondiabetic patients (20.0% vs. 12.9%; p < 0.001). The rate of the 3-year primary endpoint was similar after treatment with PCI and CABG in diabetic patients (20.7% vs. 19.3%, respectively; hazard ratio: 1.03; 95% confidence interval: 0.71 to 1.50; p = 0.87) and nondiabetic patients (12.9% vs. 12.9%, respectively; hazard ratio: 0.98; 95% confidence interval: 0.73 to 1.32; p = 0.89). All-cause death at 3 years occurred in 13.6% of PCI and 9.0% of CABG patients (p = 0.046), although no significant interaction was present between diabetes status and treatment for all-cause death (p = 0.22) or other endpoints, including the 3-year primary endpoint (p = 0.82) or the major secondary endpoints of death, MI, or stroke at 30 days (p = 0.61) or death, MI, stroke, or ischemia-driven revascularization at 3 years (p = 0.65).Conclusions
In the EXCEL trial, the relative 30-day and 3-year outcomes of PCI with everolimus-eluting stents versus CABG were consistent in diabetic and nondiabetic patients with LMCAD and site-assessed low or intermediate SYNTAX scores.(Evaluation of XIENCE versus Coronary Artery Bypass Surgery for Effectiveness of Left Main Revascularization [EXCEL]; NCT01205776) 相似文献9.
香药是古代"丝绸之路"交流发展逐渐传入中国的传统药物,补充并丰富了我国药用资源。为积极倡导国家"一带一路"建设,推进我国外来香药资源的进一步开发和利用,服务"一带一路"沿线国家广大人民尤其是少数民族人群健康用药,通过查阅大量文献,梳理了香药的"一带一路"溯源及目前研究现状;在此基础上,从中医功效角度对其进行分类,并总结常用代表性香药的香味物质基础、功效及临床用途;并提出香药的进一步开发和利用策略,以促进其在新时代"一带一路"倡议中的快速发展,进一步增强民族医药文化自信。 相似文献
10.
新型冠状病毒肺炎(coronavirus disease 2019,COVID-19)疫情严峻复杂,探讨中医药防治COVID-19处方的用药规律及特点具有重要意义。该研究收集2020年1月1日至2月18日国家卫生健康委员会,7个省市卫生健康委员会、国家中医管理局发布的和《新型冠状病毒肺炎中医诊疗手册》收录的中医药防治COVID-19诊疗方案以及3位国医大师、4位知名中医药专家所拟的方药,按照纳入、排除标准进行筛选,应用EpiData 3.0软件,建立"防治新型冠状病毒肺炎中医处方库""防治新型冠状病毒肺炎常用中药库",共收集有效中药处方93首,组成药物共计157味。应用SPSS 18.0软件进行数据分析,结果发现:①药性寒、温居多,其中性寒69味,占43.95%;性温57味,占36.31%;性热较少,仅占1.27%;②味苦、辛、甘药物较多,不同时期药味有异,初期以辛味居多,中期、重症期以苦味为主,恢复期多用甘味药;③归经以入肺、胃、心者多,入肺经最多,占24.55%;初、中期多入肺胃,重症期则入心肾;④口服药物多无毒,仅6味药物具有毒性,分别是苦杏仁、绵马贯众、重楼、细辛、半夏、炮附片;⑤以具有解表、化湿、清热、补虚、化痰止咳平喘5类功效的药物居多,初期解表与清热并重,各占18.81%;中期化痰止咳平喘药物使用多,占29.61%;重症期清热使用最多,占33.33%;恢复期补虚使用最多,占36.47%。中药防治COVID-19的药性特点和功效分布与中医对其病因、病位、病机的认识紧密相关,临证辨治尤需注重分期用药及因地制宜。 相似文献